Impact of early treatment initiation on personal income of multiple sclerosis patients.

被引：0
|
作者：
Kavaliunas, A. [1 ]
Manouchehrinia, A. [1 ]
Gyllensten, H. [1 ,2 ,3 ]
Alexanderson, K. [1 ]
Hillert, J. [1 ,4 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Ctr Person Ctr Care GPCC, Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Hlth & Care Sci, Gothenburg, Sweden
[4] Karolinska Univ Hosp, Stockholm, Sweden
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
基金：
瑞典研究理事会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
145
引用
收藏
页码：52 / 53
页数：2
相关论文
共 50 条
  • [21] The role of gut immunity in multiple sclerosis patients.
    Dalla Costa, G.
    Messina, M. J.
    Mariani, A.
    Cosorich, I.
    Farina, A.
    Rodegher, M.
    Comi, G.
    Martinelli, V.
    Falcone, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 17 - 18
  • [22] Early reduction of CD19+B-cells following treatment initiation with dimethyl fumarate in multiple sclerosis patients
    Luessi, F.
    Fleischer, V.
    Ellwardt, E.
    Graetz, C.
    Ploen, R.
    Reuter, E.
    Groppa, S.
    Zipp, F.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 753 - 754
  • [23] Factors associated with early initiation of disease-modifying drug treatment in newly-diagnosed patients with multiple sclerosis
    Edwards, Natalie C.
    Munsell, Michael
    Menzim, Joseph
    Phillips, Amy L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (08) : 1389 - 1395
  • [24] Multiple Sclerosis impact on employment and income in New Zealand
    Pearson, J. F.
    Alla, S.
    Clarke, G.
    Mason, D. F.
    Anderson, T.
    Richardson, A.
    Miller, D. H.
    Sabel, C. E.
    Abernethy, D. A.
    Willoughby, E. W.
    Taylor, B. V.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (03): : 223 - 232
  • [25] The impact of quality of life on treatment preferences in multiple sclerosis patients
    Mortensen, Gitte Lee
    Rasmussen, Peter V.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1789 - 1796
  • [26] Leflunomide inhibits neutrophil migration early after initiation of treatment in rheumatoid arthritis patients.
    Kraan, MC
    de Roster, BM
    Elferink, JG
    Post, WJ
    Breedveld, FC
    Leiden, PPT
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S192 - S192
  • [27] IMPACT OF EARLY DISEASE MODIFYING THERAPY (DMT) TREATMENT INITIATION AND USE OF HIGH-EFFICACY (HET) ON CLINICAL AND HEALTH OUTCOMES IN PATIENTS WITH MULTIPLE SCLEROSIS (MS)
    Chang, A.
    Maiese, B. A.
    Mody, L.
    Cheadle, A.
    Brown, B.
    Deshpande, C.
    VALUE IN HEALTH, 2020, 23 : S623 - S623
  • [28] Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment
    Rudick, RA
    Goodman, A
    Herndon, RM
    Panitch, HS
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (01) : 22 - 28
  • [29] Managing Multiple Sclerosis: Treatment Initiation, Modification, and Sequencing
    Freedman, Mark S.
    Selchen, Daniel
    Prat, Alexandre
    Giacomini, Paul S.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2018, 45 (05) : 489 - 503
  • [30] Parameters of pharyngeal peristalsis in multiple sclerosis and amyotropic lateral sclerosis patients.
    Easterling, C
    Ren, J
    Jaradeh, S
    Hendrickson, A
    Shaker, R
    GASTROENTEROLOGY, 1996, 110 (04) : A659 - A659
12345